| Detailed information |
|---|
| CancerLivER ID | 2260 |
| Biomarker | CDK4 |
| Biomarker Name/Symbol (given in Publication) | CDK4 |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potential prognostic and diagnostic markers for HCC associated with HCV and validated on independent dataset |
| Experimental Condition | HCC with Cirrhosis v/s HCC without Cirrhosis |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 18959789 |
| Type of Biomarker | Diagnostic and prognostic |
| Pathway | ATP binding |
| Cohort | Paired tumor and non-tumor samples of 17 patients; validation daatset:Ten samples of human DNA and RNA were extracted from PBL and normal liver tissue |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCV-associated HCC |
| Year of Publication | 2008 |
| Clinical trial | YES |
| NCT No# (Clinical trial) | NCT02465060 |